Company: INCR
Filing Date: 2025-05-01
Form Type: NT 20-F
Source: 0001641172-25-007952
Chunk: 2

Company: Intercure Ltd.
Filing Date: 2025-05-01
Form: NT 20-F
Chunk 2
---
 the reasons why a reasonable estimate of the results cannot be made.

| 2 |

<div align='center'>NLS PHARMCEUTICS LTD.

(Name of Registrant as Specified in Charter)</div>

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

| Date | April 30, 2025 |     | By: | /s/               
 Amos Cohen        |
|:-----|:---------------|:----|:----|:------------------|
|      |                |     |     | Amos              
 Cohen             |
|      |                |     |     | Chief             
 Financial Officer |

| 3 |